Hualan Biological Engineering Sets Up Asia’s Largest Blood Products Base
This article was originally published in PharmAsia News
Hualan Biological Engineering has finished the construction of its blood products base in Fuling, Sichuan province. Covering 60,000 square meters, the RMB 280 million investment houses 10,000 square meters of factory floor space. When it officially commences operation next year, the base will process 1,000 tons of blood plasma annually with output reaching RMB 480 million. This will make it Asia's largest blood product base and among the world's top three facilities. (Click here for more - Chinese Language)
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.